𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breaking the 5-year barrier: Results from the MA.17 extended adjuvant trial in women who have completed adjuvant tamoxifen treatment

✍ Scribed by Paul Goss

Book ID
119233571
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
281 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness analysis of anastrozo
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (β€˜Arimidex’, Tamoxifen Alone or in Combination) trial
✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S πŸ“‚ Article πŸ“… 2007 πŸ› Springer US 🌐 English βš– 267 KB